The Endocrine Society's new vitamin D clinical practice guidelines have sparked significant backlash from healthcare professionals who argue the recommendations ignore potential benefits and fail to address the needs of various patient populations.
The updated Canadian Task Force on Preventive Health Care guidelines recommend that breast cancer screening should be a personal choice for women aged 40-74, based on a careful consideration of potential benefits and harms.
Many US primary care providers are reluctant to adopt the updated cervical cancer screening guidelines from the American Cancer Society, which recommend starting screening at age 25 and using primary HPV testing, due to conflicting guidelines from other major organizations and concerns about efficacy and access.